|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:acquired_by
|
gptkb:Novartis_AG
gptkb:2015
|
|
gptkbp:collaborates_with
|
government agencies
academic institutions
|
|
gptkbp:developed_by
|
Pneumococcal vaccine
Flu vaccine
Men B vaccine
|
|
gptkbp:employs
|
gptkb:scientists
gptkb:researchers
|
|
gptkbp:focuses_on
|
vaccines
diagnostics
|
|
gptkbp:founded
|
gptkb:2000
|
|
gptkbp:founded_in
|
gptkb:2000
|
|
gptkbp:has_part
|
laboratories
research facilities
distribution centers
manufacturing plants
offices
|
|
gptkbp:has_product
|
gptkb:Menveo
gptkb:Bexsero
gptkb:Zy_Co_V-D
Pentacel
Fluvirin
Pediarix
|
|
gptkbp:has_research_focus
|
public health
clinical trials
infectious diseases
immunology
vaccine development
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Novartis Vaccines and Diagnostics
|
|
gptkbp:is_known_for
|
public health initiatives
vaccine innovation
global health solutions
|
|
gptkbp:is_part_of
|
life sciences
biotechnology industry
healthcare sector
|
|
gptkbp:operates_in
|
global market
biopharmaceutical market
pharmaceutical market
|
|
gptkbp:part_of
|
gptkb:Novartis_AG
|
|
gptkbp:provides
|
diagnostic tests
vaccination programs
|
|
gptkbp:supports
|
public health campaigns
research collaborations
|
|
gptkbp:was_part_of
|
gptkb:Novartis_Pharmaceuticals_Corporation
|
|
gptkbp:bfsParent
|
gptkb:Chiron_Vaccines
gptkb:CSL_Seqirus
|
|
gptkbp:bfsLayer
|
7
|